Biotech

Showing of Insights Posts
Biotech Innovations
Article
4 min
Biotech Venture capital Private Investing Program Private investing Innovation Private companies USA China Europe Private Biotech Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

China’s biotech surge (and its impact on biotech venture capital)

China’s biotech sector’s long-term potential is underpinned by lower costs, faster development timelines, and increasingly translatable clinical data. In our new paper, we explore the implications for US and European biotechs.

Continue reading

Multiple authors

event
4 min
Article
2028-01-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
nilesh-kumar1
Video
3 min
Innovation Venture capital Biotech Private Investing Program Private investing Video Private Biotech
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech innovation versus hype

Nilesh Kumar discusses the next generation of biotech disruptors in obesity, autoimmunity, and oncology, focusing on drugs that solve real-world unmet medical needs.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
event
3 min
Video
2026-06-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1349253411
Article
5 min
Private Biotech Liquid alternatives & hedge funds Biotech Health care Venture capital Article Innovation Private investments Private Investing Program Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading

Multiple authors

event
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
Article
8 min
Small-cap Global Industry Research Biotech Institutional Program Discover Large-cap Thematic solutions Article Equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading

By

Wen Shi
Wen Shi, PhD, CFA
Mark Sevecka
Mark Sevecka, PhD
event
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
Article
4 min
Private investing Private Biotech Biotech Venture capital Article Private Investing Program Private companies Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
William Craig
William Craig
event
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
5 LOAD {count} MORE

URL References

Related Insights

© Copyright 2026 Wellington Management Company LLP. All rights reserved. WELLINGTON MANAGEMENT ® is a registered service mark of Wellington Group Holdings LLP. For institutional or professional investors only.

View More